A Study to Examine the Genomic Testing Practices by Hematology/Oncology Physicians at Mayo Clinic in Florida

Overview

About this study

The purpose of this study is to examine the genomic testing practices by Hematology/Oncology physicians at Mayo Clinic in Florida in an effort to 1) catalogue the number and type of panel-based tests used as well as 2) determine how often the test findings informed the clinical decision making for the physician and their patient.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients who underwent panel-based tests in the Division of Hematology/Oncology at Mayo Clinic Florida between January 1, 2015 and December 31, 2016.

More information

Publications

Publications are currently not available
.
CLS-20357699

Mayo Clinic Footer